Nuvectis Pharma
NVCT
NVCT
11 hedge funds and large institutions have $7.2M invested in Nuvectis Pharma in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
11
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.35M | |
| 2 | +$393K | |
| 3 | +$261K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$131K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$102K |
Top Sellers
| 1 | -$1.46M | |
| 2 | -$312K | |
| 3 | -$84K | |
| 4 |
BlackRock
New York
|
-$7.49K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.16K |